KELLY EFFINGER: Open Payments
NPI 1750750352 · LOUISVILLE, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$968 in 29 payments from 9 companies in 2025. Trend: 2023 $622 · 2024 $904 · 2025 $968
Food & beverage: $968
| Company | Payments | Amount |
|---|---|---|
| Fresenius USA Marketing, Inc. | 10 | $230 |
| AstraZeneca Pharmaceuticals LP | 3 | $150 |
| Otsuka America Pharmaceutical, Inc. | 3 | $147 |
| Ardelyx, Inc. | 3 | $145 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $117 |
| Travere Therapeutics, Inc. | 2 | $58 |
| Amgen Inc. | 3 | $52 |
| Novartis Pharmaceuticals Corporation | 2 | $44 |
| Mallinckrodt Hospital Products Inc. | 1 | $25 |
Products named: VELPHORO, XPHOZAH 30 MG, Kerendia, TAVNEOS, Fabhalta, JYNARQUE, IBSRELA, TERLIVAZ.
Industry payments across KY — which companies pay providers there.
